Taysha Gene Therapies (TSHA) Shares Issued (2020 - 2026)

Taysha Gene Therapies has disclosed Shares Issued across 6 years of filings, most recently posting $516000.0 for Q1 2026.

• Shares Issued for Q1 2026 came in at $516000.0, up 588.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 912.8% YoY), and the FY2025 annual result was $1.2 million, up 1270.79% from the prior year.
• Shares Issued came in at $516000.0 for Q1 2026 at Taysha Gene Therapies, down from $1.1 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $11.3 million in Q3 2022 to a low of -$11.4 million in Q4 2022.
• The 5-year median for Shares Issued is $79500.0 (2025), against an average of -$728750.0.
• Across the five-year window, Shares Issued plunged 96.02% in 2023 and jumped 588.0% in 2026, its largest moves.
• Taysha Gene Therapies' Shares Issued stood at -$11.4 million in 2022, then jumped by 103.95% to $450000.0 in 2023, then slumped by 86.0% to $63000.0 in 2024, then soared by 1584.13% to $1.1 million in 2025, then tumbled by 51.37% to $516000.0 in 2026.
• The last three Shares Issued figures came in at $516000.0 (Q1 2026), $1.1 million (Q4 2025), and $84000.0 (Q3 2025), per Business Quant data.